UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study

Journal of endocrinological investigation, 2024-06, Vol.47 (6), p.1395-1403

2024

Volltextzugriff (PDF)

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

American journal of transplantation, 2015-07, Vol.15 (7), p.1817-1826

2015

Volltextzugriff (PDF)

The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities

Journal of viral hepatitis, 2018-07, Vol.25 (7), p.791-801

2018

Volltextzugriff (PDF)

Identification of Src tyrosine kinase as a therapeutic target in cystic fibrosis liver disease using patient specific induced pluripotent stem cells -derived cholangiocytes

Journal of hepatology, 2017, Vol.66 (1), p.S182-S182

2017

Volltextzugriff (PDF)

Expansion and Polarization of Cholangiocytes from Human Induced Pluripotent Stem Cells (Ipsc)

Journal of hepatology, 2016, Vol.64 (2), p.S181-S181

2016

Volltextzugriff (PDF)

Hepatocellular carcinoma in elderly patients referred to a tertiary center with multidisciplinary team approach: clinical presentation and outcomes

Journal of hepatology, 2017, Vol.66 (1), p.S631-S631

2017

Volltextzugriff (PDF)

Inhibition of IL-1b/STAT3/β-catenin-dependent stimulation of the CXCL10/CXCR3 axis prevents macrophage recruitment and progression of the disease in Pkhd1del4/del4 mice, a model of congenital hepatic fibrosis

Journal of hepatology, 2017, Vol.66 (1), p.S36-S37

2017

Volltextzugriff (PDF)

P1253 ACTIVATION OF PPAR-γ SIGNALING AS A NOVEL TARGET TO LIMIT NF-κB-DEPENDENT INFLAMMATION IN CYSTIC FIBROSIS BILIARY EPITHELIUM

Journal of hepatology, 2014-04, Vol.60 (1), p.S507-S507

2014

Volltextzugriff (PDF)

Inhibition of the CA2+-Inhibited Adenylyl Cyclase 5 Reduces CYST Growth in Mice with Polycystic Liver Disease (ADPKD) Caused by Defective Polycystin-2

Journal of hepatology, 2016, Vol.64 (2), p.S297-S297

2016

Volltextzugriff (PDF)

Early changes in perfusion-computed tomography scan parameters as a marker of improved outcomes in patients with hepatocellular carcinoma treated with Sorafenib

Journal of hepatology, 2017, Vol.66 (1), p.S632-S632

2017

Volltextzugriff (PDF)

P0220 : JNK signaling activated by platelet-derived growth factor D (PDGF-D) stimulates secretion of vascular endothelial growth factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastasization in cholangiocarcinoma

Journal of hepatology, 2015-04, Vol.62, p.S389-S389

2015

Volltextzugriff (PDF)

Clinical presentation and outcomes of hepatocellular carcinoma in elderly patients referred to a tertiary center: 5-Years experience

Digestive and liver disease, 2017-02, Vol.49 (1), p.e23-e23

2017

Volltextzugriff (PDF)

P1249 CFTR CONTROLS A MEMBRANE MULTI-PROTEIN COMPLEX THAT REGULATES CHOLANGIOCYTE C-SRC TYROSINE KINASE ACTIVITY AND TLR4 SIGNALING: IMPLICATIONS FOR CYSTIC FIBROSIS LIVER DISEASE (CFLD)

Journal of hepatology, 2014-04, Vol.60 (1), p.S506-S506

2014

Volltextzugriff (PDF)

P1141 : Post-translational regulation of polycystin 2 (PC2) expression as a novel mechanism of cholangiocyte reaction to biliary damage and repair

Journal of hepatology, 2015-04, Vol.62, p.S779-S780

2015

Volltextzugriff (PDF)

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of viral hepatitis, 2015-02, Vol.22 (2), p.175-183

2015

Volltextzugriff (PDF)

Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience

Journal of hepatology, 2017, Vol.66 (1), p.S631-S631

2017

Volltextzugriff (PDF)

Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota

Cellular and molecular gastroenterology and hepatology, 2019-01, Vol.8 (2), p.197-207

2019

Volltextzugriff (PDF)

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Journal of hepatology, 2017, Vol.66 (1), p.S39-S40

2017

Volltextzugriff (PDF)

P0226 : Reduction in sumoylation-dependent S100A4 nuclear import in cholangiocarcinoma by low dose paclitaxel halts tumor invasiveness and hematogenous metastatization by modulating Rho-A and Cdc42 activities

Journal of hepatology, 2015-04, Vol.62, p.S392-S392

2015

Volltextzugriff (PDF)

The Cystic Fibrosis Conductance Regular (CFTR) controls c-Src tyrosine kinase signaling and regulates innate immunity and epithelial polarity in cholangiocytes

Digestive and liver disease, 2015-02, Vol.47, p.e2-e2

2015

Volltextzugriff (PDF)

Stimulation of Nuclear Receptor PPAR-γ Limits NF-kB-dependent Inflammation in Cystic Fibrosis Biliary Epithelium

Digestive and liver disease, 2015-02, Vol.47, p.e43-e44

2015

Volltextzugriff (PDF)

Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start

Digestive and liver disease, 2017-02, Vol.49 (1), p.e68-e68

2017

Volltextzugriff (PDF)

P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis

Journal of hepatology, 2015-04, Vol.62, p.S639-S639

2015

Volltextzugriff (PDF)

JNK signaling activated by Platelet-Derived Growth Factor D (PDGF-D) stimulates secretion of Vascular Endothelial Growth Factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastatization in cholangiocarcinoma

Digestive and liver disease, 2015-02, Vol.47, p.e22-e23

2015

Volltextzugriff (PDF)

P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS

Journal of hepatology, 2014-04, Vol.60 (1), p.S493-S493

2014

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(279)

Publikationsform

Artikel
(295)
Buchkapitel
(3)

Sprache

Englisch
(298)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(103)
Science & Technology
(102)
Life Sciences & Biomedicine
(98)
Humans
(80)
Gastroenterology & Hepatology
(57)
Biological And Medical Sciences
(48)
Male
(39)
Animals
(35)
Medical Sciences
(34)
Female
(30)
Adult
(27)
Middle Aged
(26)
Aged
(18)
Fundamental And Applied Biological Sciences. Psychology
(16)
Liver Diseases
(16)
Rats
(16)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Liver Transplantation
(14)
Hydrogen-Ion Concentration
(13)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities

Identification of Src tyrosine kinase as a therapeutic target in cystic fibrosis liver disease using patient specific induced pluripotent stem cells -derived cholangiocytes

Expansion and Polarization of Cholangiocytes from Human Induced Pluripotent Stem Cells (Ipsc)

Hepatocellular carcinoma in elderly patients referred to a tertiary center with multidisciplinary team approach: clinical presentation and outcomes

Inhibition of IL-1b/STAT3/β-catenin-dependent stimulation of the CXCL10/CXCR3 axis prevents macrophage recruitment and progression of the disease in Pkhd1del4/del4 mice, a model of congenital hepatic fibrosis

P1253 ACTIVATION OF PPAR-γ SIGNALING AS A NOVEL TARGET TO LIMIT NF-κB-DEPENDENT INFLAMMATION IN CYSTIC FIBROSIS BILIARY EPITHELIUM

Inhibition of the CA2+-Inhibited Adenylyl Cyclase 5 Reduces CYST Growth in Mice with Polycystic Liver Disease (ADPKD) Caused by Defective Polycystin-2

Early changes in perfusion-computed tomography scan parameters as a marker of improved outcomes in patients with hepatocellular carcinoma treated with Sorafenib

P0220 : JNK signaling activated by platelet-derived growth factor D (PDGF-D) stimulates secretion of vascular endothelial growth factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastasization in cholangiocarcinoma

Clinical presentation and outcomes of hepatocellular carcinoma in elderly patients referred to a tertiary center: 5-Years experience

P1249 CFTR CONTROLS A MEMBRANE MULTI-PROTEIN COMPLEX THAT REGULATES CHOLANGIOCYTE C-SRC TYROSINE KINASE ACTIVITY AND TLR4 SIGNALING: IMPLICATIONS FOR CYSTIC FIBROSIS LIVER DISEASE (CFLD)

P1141 : Post-translational regulation of polycystin 2 (PC2) expression as a novel mechanism of cholangiocyte reaction to biliary damage and repair

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience

Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

P0226 : Reduction in sumoylation-dependent S100A4 nuclear import in cholangiocarcinoma by low dose paclitaxel halts tumor invasiveness and hematogenous metastatization by modulating Rho-A and Cdc42 activities

The Cystic Fibrosis Conductance Regular (CFTR) controls c-Src tyrosine kinase signaling and regulates innate immunity and epithelial polarity in cholangiocytes

Stimulation of Nuclear Receptor PPAR-γ Limits NF-kB-dependent Inflammation in Cystic Fibrosis Biliary Epithelium

Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start

P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis

JNK signaling activated by Platelet-Derived Growth Factor D (PDGF-D) stimulates secretion of Vascular Endothelial Growth Factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastatization in cholangiocarcinoma

P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS

Suchergebnisse filtern